Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer’s disease

Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer’s disease

Abstract Background Neuroinflammation has gained increasing attention as a potential contributing factor in Alzheimer’s disease (AD) pathology. A clinical cerebrospinal fluid biomarker capable of monitoring this process during the course of the disease has yet to emerge, chiefly owing to contradicto...

Full description

Bibliographic Details
Main Authors: Frederic Brosseron, Andreas Traschütz, Catherine N. Widmann, Markus P. Kummer, Pawel Tacik, Francesco Santarelli, Frank Jessen, Michael T. Heneka
Format: Article
Language:English
Published: BMC 2018-02-01
Series:Alzheimer’s Research & Therapy
Subjects:
Alzheimer’s disease
Mild cognitive impairment
Cerebrospinal fluid
Biomarker
Inflammation
Discriminative power
Online Access:http://link.springer.com/article/10.1186/s13195-018-0353-3

Internet

http://link.springer.com/article/10.1186/s13195-018-0353-3

Similar Items